10 1 paraneoplastic syndromes (1)
TRANSCRIPT
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
1/31
Paraneoplastic
Syndromes
Krzysztof RonowskiClinic of Oncology
Pozna University of Medical Sciences
Elective Course in Oncology for Medical
Students
18.08.2011
Pozna, Poland
http://www.ump.edu.pl/pol/?department=12 -
8/10/2019 10 1 Paraneoplastic Syndromes (1)
2/31
Paraneoplastic Syndromes
- Different symptoms or pathological
disorders not directly caused by the
presence of malignant disease
- Distal manifestation from the primary
localization of the neoplasm or its
metastases
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
3/31
Paraneoplastic syndromes are
observed in the course of more
than 15% of all cases ofmalignant diseases
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
4/31
Diagnosis of paraneoplastic
syndromes
Different pathological situations, like
chronic organs insufficiency,
infections, endocrine disorders cangive similar symptoms
Diagnosis of paraneoplastic syndromesis diagnosis of exclusion other
diseases
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
5/31
Clinical appearance of
paraneoplastic syndromes
Symptoms preceding clinicalmanifestation of neoplasm
Symptoms co-existing with signs ofactive malignancy
Symptoms observed after failure oftreatment, present in late stages ofadvanced/metastatic disease
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
6/31
Establishing diagnosis ofparaneoplastic syndromes
appearing before manifestation
of malignant disease could beessential for early detection of
neoplasm
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
7/31
Therapeutic approach
Effective treatment of malignant
disease
Symptomatic treatment
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
8/31
Classification of paraneoplastic
syndromes
Common classification based on the
most affected tissue, organ or system
Classification according to mechanism
of initiation particular symptoms andsyndromes
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
9/31
Classification of paraneoplastic
syndromes cont.
Two basic mechanisms of appearance ofparaneoplastic syndromes:
- endocrine, as a result of excretion ofhormones, hormone related peptides orcytokines
- autoimmunological, as a consequence ofantigen similarity between malignant andnormal tissues
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
10/31
Endocrinological manifestations
of neoplasmatic diseases Inappropriate secretion of antidiuretic hormone
hyponatremia
Ectopic secretion of PTH or PTHrP hypercalcemia
Ectopic secretion of ACTH and ACTH-likesubstances Cushings syndrome
Hypoglycemia as a result of ectopic secretion ofinsulin-like growth factor t.II
Gonadotropins (example gynecomastia caused by
germ cell tumors secreting beta-hCG)
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
11/31
Hematological paraneoplastic
syndromes
Erythrocytosis due to secretion oferythrtopoetin or/and cytokines enhancingits effect (renal carcinoma, hepatoma,phoechromocytoma)
Anemia the most common is normocyticanemia of chronic disease, but also observed
autoimmune hemolytic anemia in the courseof limphoid malignances or microangiopaticanemia
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
12/31
Hematological paraneoplastic
syndromes cont.
Granulocytosis associated with ectopicsecretion of G-CSF and GM-CSF,
observed in lymphoid malignanciesand tumors of digestive tract
Eosinophilia caused by tumor-associated eosinophil-stilmulatingfactor (glycoprotein of 45kd) producedby Hodgkins cells
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
13/31
Hematological paraneoplastic
syndromes cont.
Coagulopathies
Disseminated IntravascularCoagulation (DIC) as an effect ofthrombocytopenia, hypofibrinogenemiaand activation of fibrinolisis; requiringboth effective anti-cancer therapy andsymptomatic therapy as life-threateningstatus
P l ti d
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
14/31
Paraneoplastic syndromes
connected with nutrition and
digestive system
Anorexia misperception of signals infeeding centre caused by inadequate level of
serotonin due to secretion of differentcytokines (TNF, IL1, IL6) by cancer cells
Protein losing enteropathy
Hypercatabolism stimulated by TNF- alfa, IL1,IL6 and other cytokines observed mainly in
muscle and fat tissue
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
15/31
Paraneoplastic syndromes
connected with nutrition cont
Cachexia as a result of anorexia and
increased catabolism paraneoplasticsyndrome often observed in advanced
stages of malignant diseases after
failure of anticancer treatment; requiressymptomatic treatment for quality of
life improvement
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
16/31
Nephrological paraneoplastic
syndromes
Acute and chronic glomerulonephritisas a result of autoimmunological
reaction against elements of kidneysglomeruli
Renal failure due to precipitation ofureic acid, pathological proteins orcalcium in the course of paraneoplasticmetabolic disorders
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
17/31
Cutaneous paraneoplastic
syndromes
Effect of autoimmunological reactionsagainst different dermal and epidermal
structures
Often preceding manifestation ofmalignancy
Proper diagnosis may lead to earlydetection of cancer
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
18/31
Cutaneous paraneoplastic syndromes
cont.
Leser - Trelat syndrome - diffuse seborhoic papillomatosisaffecting mainly trunk; early sign of many malignancies
especially deriving form gastro-intestinal tract; caused by
secretion of TGF and overexpression of EGFR
http://morningreporttgh.blogspot.com/2009/05/less-is-more.html
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
19/31
Cutaneous paraneoplastic syndromes
cont.
Sweet syndrome lupus-like, painful spots localizedon face and neck appearing sometimes few yearsbefore manifestation of lymphoid malignancies
http://dermatology.cdlib.org/DOJvol5num1/therapy/sweets.html
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
20/31
Cutaneous paraneoplastic syndromes
cont.
Dermatology Online Journal 10 (1): 21
Paraneoplastic acrokeratosis
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
21/31
Cutaneous paraneoplastic syndromes
cont.
Pemphigus result of
autoimmunological reaction against
desmosomes
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
22/31
Cutaneous paraneoplastic syndromes
cont.
Dermatitis herpetiformes localized on knees, elbows
and lumbar region early manifestation of small
bowl lymphomas
Pruritis- one of general symptoms of hematological
malignancies as an effect of IL1, IL6 and TNF
secretion by lymphoid malignant cells or/and
activated lymphocytes T infiltrating different solid
tumors
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
23/31
Osteoarticular and muscle systems
paraneoplastic syndromes
Hypertrophic osteoarthropathy digitalclubbing, periostitis of tubular bone, generalized arthritis,
syndrome observed in the course of many solid tumors,
requiring besides primary treatment also effective symptomatic
treatment with steroids and non-steroid anti-inflammatory
drugs
http://cancergrace.org/lung/2009/02/10/hpoa/
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
24/31
Osteoarticular and muscle systems
paraneoplastic syndromes
Palmar Fasciitis and Polyarthritis
From medal.org, the largest collection of medical algorithms,
Institute of Algorithmic Medicine Under License to Medal.org Ltd
http://www.medal.org/http://www.medal.org/ -
8/10/2019 10 1 Paraneoplastic Syndromes (1)
25/31
Osteoarticular and muscle systems
paraneoplastic syndromes cont.
Myositis(ovarian cancer, NHL, thyroid cancer
http://www.radiologyassistant.nl/en/4ae30bb452e53
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
26/31
Neurological paraneoplastic
syndromes
Antigen similarity between malignant and nervoustissue causing autoimmunological reactions e.g.against myelin associated glycoprotein (MAG)
Acute or subacute inflammations often ofprogressive, degenerative and irreversible character
Often preceding manifestation of neoplasm,diagnosis difficult to establish, resistant for any kindof therapy; diagnosis of malignant disease is setoften during autopsy after non effective treatment ofneurological disorders
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
27/31
Neurological paraneoplastic
syndromes cont.
Paraneoplastic cerebellar degeneration
subacute inflammatory- degenerative process in Purkynys cells,
leading to ataxia, dysartria, progressing dementia; difficult todiagnose- MRI and CT scans non specific, sometimes elevated level
of IgG in cerebrospinal fluid; without effective treatment of
underlying malignancy lethal character of this syndrome
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
28/31
Paraneoplastic cerebellar
degeneration
http://www.penncancer.org/pnd/subpage
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
29/31
Neurological paraneoplastic
syndromes cont.
Retinal degeneration
Paraneoplastic opsoclonus-myoclonus
Limbic encephalitis
Sensory and motor neuropathy
Sensimotor peripheral neuropathy
Pseudomiastenic Lambert Eaton syndrome (small celllung cancer)
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
30/31
Miscellanenous Paraneoplastic
Syndromes
Fever one of general symptoms oflymphoid malignances; influence ofinterleukines on metabolism of arachidonic
acid leading to increased level ofprostaglandin E2, which stimulatesthermoregulatory centre;
In case of solid tumors the same effectachieved by elevated level of interferons andTNF produced by healthy cells as a result ofpresence of malignant tissue
-
8/10/2019 10 1 Paraneoplastic Syndromes (1)
31/31
Paraneoplastic Syndromes
Knowledge of symptoms and syndromes not directlyconnected with primary site of malignant tumor isimportant for its early detection
Resolution of paraneoplastic syndromes may be aprognostic factor in assessment of efficacy ofanticancer treatment
The best mode of treatment of paraneoplasticsyndromes is effective treatment of malignantdisease but for improvement of quality of patientslife, they sometimes require symptomatic treatment